Asia Pacific Pulmonary Drug Delivery Systems Market Outlook

the asia pacific pulmonary drug delivery systems market is expected to surge in the years 2018 to 2032. the rise in prevalence of respiratory diseases, ongoing development of inhalation technology and increasing preference for inhaled drug delivery systems are some of the major factors driving the growth of the asia pacific pulmonary drug delivery system market. the market is mainly driven by the growing prevalence of chronic and infectious obstructive pulmonary diseases (copd). in 2020, the incidence of copd among adults in the asia pacific region was estimated to about 21.3 million. the growing geriatric population in the region is further driving the growth of the market. in addition, with recent advancements in inhalation technology,the asia pacific pulmonary drug delivery system market is expected to witness further growth in the years 2018-2032. the innovatively designed inhalation devices enable delivery of accurate therapeutic doses of medication with minimum wastage of the drugs. furthermore, widespread use of inhalation therapy and growing number of patents protect the original manufacturers of inhalation products are driving theasia pacific pulmonary drug delivery system market. governments and health organizations in the region such as the who, are increasing their funding for research and clinical trials related to inhalation delivery system which is further fuelling the growth of the market. moreover, with the growing incidence of acute respiratory diseases among children, the emergence of pediatric inhalers that deliver micro doses to children is increasing the scope of the market. moreover, for inhalation medications, high cost and complexity of manufacturing are the major restraint for the market. similarly, side effects associated with the use of inhalation medications are deterring the growth of the market. despite some restraints, the industry is expected to witness significant growth in the asia pacific pulmonary drug delivery systems market in the 2018-2032 period. growing expansion ofinhalation delivery technology and increasing investment in r&d of inhalation technologies are expected to drive the growth of the asia pacific pulmonary drug delivery systems market in the forecast period.